cilostazol has been researched along with 1-methyl-3-isobutylxanthine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristol, JA; Cain, MH; Weishaar, RE | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Hidaka, H; Ishikawa, T; Kimura, Y; Sakurai, K; Tani, T | 1 |
| Onaya, T; Shindo, H; Tawata, M | 1 |
| Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
| Arita, M; Dohi, K; Kiyosue, T; Matsui, K; Wang, JC | 1 |
| Kawasaki, T; Kobayashi, Y; Nakamura, H; Oki, Y; Shimizu, E; Yoshimi, T | 1 |
| Hirose, T; Kasayama, S; Kurebayashi, S | 1 |
| Colman, RW; Zhang, W | 1 |
1 review(s) available for cilostazol and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity | 1985 |
1 trial(s) available for cilostazol and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Blood Platelets; Calcium; Calcium Signaling; Cilostazol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cytoskeleton; Enzyme Activation; Hemostatics; Humans; Hydrolysis; Milrinone; Phosphodiesterase Inhibitors; Phosphoprotein Phosphatases; Phosphorylation; Platelet Activation; Protein Phosphatase 1; Proto-Oncogene Proteins c-akt; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Tetrazoles; Thrombin | 2007 |
7 other study(ies) available for cilostazol and 1-methyl-3-isobutylxanthine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells.
Topics: 1-Methyl-3-isobutylxanthine; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Blood Platelets; Cells, Cultured; Cilostazol; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Platelet Aggregation; Tetrazoles; Umbilical Cord; Vasodilator Agents | 1992 |
Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Cilostazol; Cyclic AMP; Diabetes Mellitus, Experimental; Iloprost; In Vitro Techniques; Inositol; Kinetics; Male; Myelin Sheath; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Reference Values; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Tetrazoles | 1993 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |
Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium Channels; Cardiotonic Agents; Cilostazol; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Milrinone; Myocardial Contraction; Papillary Muscles; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyridazines; Tetrazoles | 1999 |
OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Actins; Animals; Cell Differentiation; Cell Division; Cells, Cultured; Cilostazol; Culture Media; Cyclic AMP; Desmin; Dose-Response Relationship, Drug; Isoenzymes; Liver; Male; Muscle, Smooth; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Xanthines | 1999 |
Antiplatelet agent cilostazol potentiates adipocyte differentiation of 3T3-L1 cells.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Adipocytes; Animals; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cilostazol; Dexamethasone; Gene Expression Regulation; Insulin; Mice; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Stearoyl-CoA Desaturase; Tetrazoles | 2001 |